Early achievement of measurable residual disease (MRD)-negative complete remission as predictor of outcome after myeloablative allogeneic hematopoietic cell transplantation in acute myeloid leukemia

Bone Marrow Transplantation, Published online: 04 November 2019; doi:10.1038/s41409-019-0739-2Early achievement of measurable residual disease (MRD)-negative complete remission as predictor of outcome after myeloablative allogeneic hematopoietic cell transplantation in acute myeloid leukemia

Source: Bone Marrow Transplantation - November 3, 2019 Category: Hematology Authors: Alexander P. Hoffmann Ashley L. Besch Megan Othus Linde M. Morsink Brent L. Wood Marco Mielcarek Elihu H. Estey Frederick R. Appelbaum Roland B. Walter Source Type: research